The effect of cimetidine, a new histamine H2-receptor antagonist, on meal-stimulated acid secretion, serum gastrin, and gastric emptying in patients with duodenal ulcer
- PMID: 6359
The effect of cimetidine, a new histamine H2-receptor antagonist, on meal-stimulated acid secretion, serum gastrin, and gastric emptying in patients with duodenal ulcer
Abstract
Meal-stimulated acid secretion, measured by in vivo intragastric titration, was progressively inhibited by increasing oral doses of cimetidine (25 to 400 mg). Four hundred milligrams suppressed acid secretion by 73% for the first 3 hr after the meal, whereas it inhibited acid secretion by 94% during the 30-min period of maximal inhibition. The dose of cimetidine required to suppress acid secretion by 50% during the 30-min period of maximal inhibition was 25 mg. The duration of action of a 300-mg dose was at least 7 hr. Cimetidine was equally effective in inhibiting meal-stimulated acid secretion at two physiological intragastric pH levels (5.0 and 2.5). Cimetidine had no effect on serum gastrin concentration when intragastric pH was maintained at 5.0, but when pH was allowed to seek its own level, serum gastrin concentration was higher after cimetidine than after placebo. Cimetidine had no effect on gastric emptying. No side effects were noted in any patients.
Similar articles
-
Inhibition of gastric acid secretion by cimetidine in patients with duodenal ulcer.N Engl J Med. 1975 Aug 21;293(8):371-5. doi: 10.1056/NEJM197508212930802. N Engl J Med. 1975. PMID: 239346 Clinical Trial.
-
Cimetidine suppression of nocturnal gastric secretion in active duodenal ulcer.N Engl J Med. 1976 Apr 8;294(15):801-4. doi: 10.1056/NEJM197604082941502. N Engl J Med. 1976. PMID: 2870 Clinical Trial.
-
Effect of H2-receptor antagonists on gastric acid secretion and serum gastrin concentration: a review.Gastroenterology. 1978 Feb;74(2 Pt 2):366-70. Gastroenterology. 1978. PMID: 23338 Clinical Trial.
-
Cholecystokinin in the control of gastric acid and plasma gastrin and somatostatin secretion in healthy subjects and duodenal ulcer patients before and after eradication of Helicobacter pylori.J Physiol Pharmacol. 1994 Dec;45(4 Suppl 1):3-66. J Physiol Pharmacol. 1994. PMID: 7787215 Review.
-
Cimetidine: a review of its pharmacological properties and therapeutic efficacy in peptic ulcer disease.Drugs. 1978 Feb;15(2):93-131. doi: 10.2165/00003495-197815020-00002. Drugs. 1978. PMID: 342231 Review.
Cited by
-
Misoprostol, a synthetic PGE1 analog, in the treatment of duodenal ulcers. A multicenter double-blind study.Dig Dis Sci. 1985 Nov;30(11 Suppl):147S-158S. doi: 10.1007/BF01309402. Dig Dis Sci. 1985. PMID: 3932048 Clinical Trial.
-
Relationship among acid secretion, antral distension, and liquid gastric emptying in active and healed duodenal ulcer.Dig Dis Sci. 1997 Dec;42(12):2426-31. doi: 10.1023/a:1018883722181. Dig Dis Sci. 1997. PMID: 9440615
-
Evaluation of antisecretory activity of misoprostol in duodenal ulcer patients using long-term intragastric pH monitoring.Dig Dis Sci. 1988 Mar;33(3):293-7. doi: 10.1007/BF01535752. Dig Dis Sci. 1988. PMID: 3125025 Clinical Trial.
-
Metiamide: more than an H2-receptor antagonist.Am J Dig Dis. 1978 Feb;23(2):169-72. doi: 10.1007/BF01073195. Am J Dig Dis. 1978. PMID: 203185
-
Gastric secretory conditions and plasma gastrin levels in rats after prolonged treatment with cimetidine.Dig Dis Sci. 1984 Jan;29(1):40-5. doi: 10.1007/BF01296860. Dig Dis Sci. 1984. PMID: 6692731
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources